Panagora Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-651
| Closed | -$196K | – | 2843 |
|
|
2021
Q1 | $196K | Sell |
651
-411
| -39% | -$124K | ﹤0.01% | 1727 |
|
|
2020
Q4 | $399K | Sell |
1,062
-727
| -41% | -$273K | ﹤0.01% | 1315 |
|
|
2020
Q3 | $549K | Sell |
1,789
-2
| -0.1% | -$614 | ﹤0.01% | 1126 |
|
|
2020
Q2 | $673K | Sell |
1,791
-172
| -9% | -$64.6K | ﹤0.01% | 1085 |
|
|
2020
Q1 | $447K | Buy |
1,963
+780
| +66% | +$178K | ﹤0.01% | 1170 |
|
|
2019
Q4 | $626K | Buy |
+1,183
| New | +$626K | ﹤0.01% | 1225 |
|
|
2016
Q3 | – | Sell |
-81
| Closed | -$59K | – | 2431 |
|
|
2016
Q2 | $59K | Buy |
+81
| New | +$59K | ﹤0.01% | 2028 |
|
|
2014
Q2 | – | Sell |
-647
| Closed | -$1.06M | – | 2346 |
|
|
2014
Q1 | $1.06M | Buy |
+647
| New | +$1.06M | 0.01% | 1156 |
|